Bellevue Life Sciences Acquisition (BLAC) Competitors $11.27 +0.01 (+0.09%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BLAC vs. LAKE, PDEX, BWAY, NVRO, SRTS, ZJYL, TLSI, TELA, GUTS, and FONRShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Lakeland Industries (LAKE), Pro-Dex (PDEX), BrainsWay (BWAY), Nevro (NVRO), Sensus Healthcare (SRTS), Jin Medical International (ZJYL), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), and FONAR (FONR). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Lakeland Industries Pro-Dex BrainsWay Nevro Sensus Healthcare Jin Medical International TriSalus Life Sciences TELA Bio Fractyl Health FONAR Bellevue Life Sciences Acquisition (NASDAQ:BLAC) and Lakeland Industries (NASDAQ:LAKE) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Is BLAC or LAKE more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Lakeland Industries' net margin of -0.42%. Lakeland Industries' return on equity of 1.66% beat Bellevue Life Sciences Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Bellevue Life Sciences AcquisitionN/A N/A N/A Lakeland Industries -0.42%1.66%1.14% Do analysts rate BLAC or LAKE? Lakeland Industries has a consensus price target of $27.50, suggesting a potential upside of 20.19%. Given Lakeland Industries' stronger consensus rating and higher possible upside, analysts plainly believe Lakeland Industries is more favorable than Bellevue Life Sciences Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bellevue Life Sciences Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lakeland Industries 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor BLAC or LAKE? In the previous week, Lakeland Industries had 11 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 11 mentions for Lakeland Industries and 0 mentions for Bellevue Life Sciences Acquisition. Lakeland Industries' average media sentiment score of 0.35 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the news media. Company Overall Sentiment Bellevue Life Sciences Acquisition Neutral Lakeland Industries Neutral Does the MarketBeat Community prefer BLAC or LAKE? Lakeland Industries received 202 more outperform votes than Bellevue Life Sciences Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformBellevue Life Sciences AcquisitionN/AN/ALakeland IndustriesOutperform Votes20261.77% Underperform Votes12538.23% Which has more risk and volatility, BLAC or LAKE? Bellevue Life Sciences Acquisition has a beta of -0.03, meaning that its stock price is 103% less volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Which has preferable valuation and earnings, BLAC or LAKE? Lakeland Industries has higher revenue and earnings than Bellevue Life Sciences Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ALakeland Industries$151.82M1.12$5.43M-$0.09-254.22 Do insiders and institutionals hold more shares of BLAC or LAKE? 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 33.7% of Bellevue Life Sciences Acquisition shares are owned by company insiders. Comparatively, 4.2% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryLakeland Industries beats Bellevue Life Sciences Acquisition on 11 of the 13 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$45.54M$419.63M$118.84M$9.07BDividend YieldN/A6.33%5.15%4.22%P/E RatioN/A2.511.5317.19Price / SalesN/A126.891.33116.80Price / CashN/A61.1578.6637.86Price / BookN/A84.16519.874.78Net IncomeN/A$33.84M$2.37M$225.60M7 Day Performance-0.44%9.47%0.37%-1.23%1 Month Performance-3.01%44.42%46.10%3.37%1 Year Performance7.64%26.09%23.45%16.58% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$11.27+0.1%N/A+7.6%$45.54MN/A0.00N/ALAKELakeland Industries4.5837 of 5 stars$23.88+5.2%$26.50+11.0%+28.5%$176.86M$151.82M-252.221,750Analyst ForecastAnalyst RevisionPDEXPro-Dex2.0616 of 5 stars$48.48-1.9%$52.00+7.3%+181.2%$158.00M$56.80M31.48140BWAYBrainsWay3.9057 of 5 stars$9.46+0.4%$13.17+39.2%+40.9%$157.77M$38.63M95.20120NVRONevro2.1372 of 5 stars$4.15+2.0%$8.05+94.0%-82.0%$155.50M$425.17M-2.231,215Analyst ForecastSRTSSensus Healthcare3.9962 of 5 stars$7.97-2.3%$12.50+56.8%+186.3%$130.63M$24.41M14.3240Positive NewsZJYLJin Medical InternationalN/A$0.80+2.3%N/A-99.0%$123.40M$19.82M0.00245Gap DownTLSITriSalus Life Sciences4.021 of 5 stars$3.88-0.8%$12.08+211.4%-50.5%$118.31M$26.89M-1.57106Analyst ForecastInsider TradeNews CoveragePositive NewsGap UpTELATELA Bio2.9938 of 5 stars$2.79+0.7%$9.25+231.5%-49.8%$109.90M$58.45M-1.64120GUTSFractyl Health0.8828 of 5 stars$2.11+3.4%$22.00+942.7%N/A$101.49M$120,000.00-0.17102FONRFONAR1.0041 of 5 stars$15.74+1.4%N/A-25.8%$99.60M$102.01M11.24480 Related Companies and Tools Related Companies LAKE Competitors PDEX Competitors BWAY Competitors NVRO Competitors SRTS Competitors ZJYL Competitors TLSI Competitors TELA Competitors GUTS Competitors FONR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLAC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
